Services-Commercial Physical & Biological Research · DE · CIK 1668397
Medpace provides scientifically-driven outsourced clinical development services for drug, biologic, and device industries
Comparable business profile · signals at a glance
In the 90 days to Mar 17, 2026: 1 sold $14.4M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 17, 2026 | Geiger Jesse JPresident | Sell | 31,707 | $455.30 | $14.4M |
| Dec 3, 2025 | Troendle August J.CEO | Sell | 668 | $590.69 | $395K |
| Dec 2, 2025 | Troendle August J.CEO | Sell | 5,698 | $590.47 | $3.4M |
| Dec 1, 2025 | Troendle August J.CEO | Sell | 23,178 | $593.25 | $13.8M |
| Nov 28, 2025 | Troendle August J.CEO | Sell | 15,151 | $593.46 | $9.0M |
| Nov 26, 2025 | Troendle August J.CEO | Sell | 41,331 | $606.88 | $25.1M |
| Nov 25, 2025 | Troendle August J.CEO | Sell | 42,392 | $615.52 | $26.1M |
| Nov 24, 2025 | Troendle August J.CEO | Sell | 59,025 | $607.78 | $35.9M |
| Nov 24, 2025 | Burwig Susan EExec. VP, Operations | Sell | 20,000 | $609.15 | $12.2M |
| Nov 21, 2025 | Troendle August J.CEO | Sell | 21,858 | $592.18 | $12.9M |
| Nov 21, 2025 | Brady Kevin M.CFO & Treasurer | Sell | 3,000 | $590.35 | $1.8M |
| Nov 20, 2025 | Troendle August J.CEO | Sell | 6,830 | $598.49 | $4.1M |
| Nov 19, 2025 | Troendle August J.CEO | Sell | 23,862 | $592.07 | $14.1M |
| Nov 18, 2025 | Troendle August J.CEO | Sell | 7,191 | $590.84 | $4.2M |
| Nov 17, 2025 | Troendle August J.CEO | Sell | 6,047 | $591.00 | $3.6M |
| Nov 14, 2025 | Troendle August J.CEO | Sell | 14,747 | $595.26 | $8.8M |
| Nov 14, 2025 | Kraft Robert O.Director | Sell | 6,472 | $591.85 | $3.8M |
| Nov 13, 2025 | Troendle August J.CEO | Sell | 5,128 | $601.37 | $3.1M |
| Nov 12, 2025 | Troendle August J.CEO | Sell | 5,312 | $603.23 | $3.2M |
| Nov 11, 2025 | Burwig Susan EExec. VP, Operations | Sell | 18,000 | $605.00 | $10.9M |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.